BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
12 hedge funds and large institutions have $127K invested in Baudax Bio, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$55.8K | |
| 2 | +$42.3K | |
| 3 | +$3K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.42K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.79K |
Top Sellers
| 1 | -$12.2K | |
| 2 | -$9.57K | |
| 3 | -$226 | |
| 4 |
Morgan Stanley
New York
|
-$2 |